Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.62 |
| ▸ | ARG2 | P78540 | 4/20 | 0.56 |
| ▸ | ARG1 | P05089 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | GRM8 | O00222 | 1/20 | 0.54 |
| ▸ | GRM6 | O15303 | 1/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.54 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.54 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.54 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.54 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851717 | 1.00 | GSR (0.62) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL27471379 | 1.00 | GSR (0.62) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL8234491 | 0.95 | GSR (0.70) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL10135848 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL29387596 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL15987065 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL17323357 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL29289 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL29291 | 0.92 | GSR (0.71) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL21689907 | 0.86 | GSR (0.80) | GSRARG2ARG1CYP1A2GRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390938-A | Exendin-4 analogues | TXP制药股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-119451988-B | Anti-B7-H3 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119894929-A | Cancer treatment using PD-1 or PD-L1 inhibitors and antibody drug conjugates targeting Claudin 18.2 | 礼新医药科技(上海)有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118994403-B | Anti-glypican 3 antibodies | 乐普创一生物科技（上海）有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119470884-A | Pharmacokinetic immunoassay for inhibiting interference | 豪夫迈·罗氏有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119451988-A | Anti-B7-H3 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119080937-A | Anti-glypican 3 antibodies | 乐普创一生物科技（上海）有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-118994403-A | Anti-glypican 3 antibodies | 乐普创一生物科技（上海）有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118946590-A | Anti-5T 4 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118891273-A | Annexin A1 derived polypeptide analogs | 雷索特制药股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-6583266-B1 | Peptide for use in the diagnosis and treatment of skin disorders and tuberculosis | GENOME THERAPEUTICS CORPORATION | 2003-06-24 | — | — | US | disclosed |
| US-20020197704-A1 | Nucleic acid molecule, comprising a nucleic acid coding for a polypeptide with chorismate mutase activity | RHEIN BIOTECH GESELLSCHAFT FUR NEUE BIOTECHNOLOGISHE PROZESSE UND PRODUKTE MBH (DE) | 2002-12-26 | — | — | US | disclosed |
| US-20020177551-A1 | Compositions and methods for treatment of neoplastic disease | TERMAN DAVID S (US) | 2002-11-28 | — | — | US | disclosed |
| US-6458589-B1 | CULTURED IN PRESENCE OF DIFFERENTIATION AGENT; DRUG SCREENING; REGENERATING LIVER FUNCTION | GERON CORPORATION | 2002-10-01 | — | — | US | disclosed |
| EP-0772628-B1 | PEPTIDE DERIVED RADIONUCLIDE CHELATORS | RESOLUTION PHARM INC (CA) | 2000-07-19 | — | — | EP | disclosed |
| US-5976495-A | Peptide derived radionuclide chelators | RESOLUTION PHARMACEUTICALS, INC. (CA) | 1999-11-02 | — | — | US | disclosed |
| EP-0606411-B1 | NOVEL COMPOUNDS AND CONJUGATES | BEHRING DIAGNOSTICS INC (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5780006-A | RADIOLABELED TRIPEPTIDE COMPLEX CONJUGATED TO OLIGO- OR POLYPEPTIDE TARGETING AGENT; MEDICAL DIAGNOSIS | RESOLUTION PHARMACEUTICALS INC. (CA) | 1998-07-14 | — | — | US | disclosed |
| US-5662885-A | FOR USE IN IMAGING SITES OF DIAGNOSTIC INTEREST | RESOLUTION PHARMACEUTICALS INC. (CA) | 1997-09-02 | — | — | US | disclosed |
| US-5294536-A | Immunoassay using a solid support having a protein linked to a solid support by a carbamic acid-containing maleiimide | PB DIAGNOSTIC SYSTEMS, INC. (US) | 1994-03-15 | — | — | US | disclosed |